MAZE Maze Therapeutics, Inc. - Common Stock
MAZE Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
MAZE Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
MAZE Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 7 38,9%
- Kauf 10 55,6%
- Halten 1 5,6%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
11 Analysten · 2026-08-15Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.45 | $-0.56 | 0.11% |
| 31. Dezember 2025 | $-0.65 | $-0.73 | 0.08% |
| 30. September 2025 | $-0.66 | $-0.72 | 0.06% |
| 30. Juni 2025 | $-0.77 | $-0.87 | 0.10% |
| 31. März 2025 | $-1.15 | $-0.77 | -0.38% |
| 31. Dezember 2024 | $-18.32 | $0.46 | -18.8% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| MAZE | $2.04B | -13.6 | — | — | -598.9% | — |
| TRLV | — | — | -0.45% | -10.3% | -10.4% | 60.2% |
| ANIP | $1.78B | 23.8 | 43.8% | 8.9% | 16.6% | — |
| ETON | $457M | — | 104.9% | -5.8% | -18.4% | 53.5% |
| AVLN | — | — | — | — | — | — |
| INVA | — | 6.1 | 14.7% | — | — | — |
| LBRX | $563M | -7.1 | — | — | -25.5% | — |
| HROW | $1.82B | -350.0 | 36.4% | -1.9% | -8.4% | 75.0% |
| XERS | $1.30B | — | 43.7% | 0.19% | -19.7% | — |
| PAHC | — | 21.5 | 27.4% | 3.7% | 17.8% | 30.9% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | · | $168M | |
| R&D Expense | $108M | $83M | |
| SG&A Expense | $34M | $26M | |
| Operating Expenses | $143M | $110M | |
| Operating Income | $-143M | $58M | |
| Pretax Income | $-131M | $53M | |
| Income Tax | $0 | $1M | |
| Net Income | $-131M | $52M | |
| EPS (Basic) | $-3.05 | $1.42 | |
| EPS (Diluted) | $-3.05 | $1.25 | |
| Shares (Basic) | 42,976,024 | 2,396,094 | |
| Shares (Diluted) | 42,976,024 | 2,730,299 | |
| EBITDA | $-143M | · |
Bilanz 20
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $189M | $197M | |
| Short-term Investments | $153M | · | |
| Prepaid Expense | $8M | $5M | |
| Current Assets | $350M | $202M | |
| PP&E (Net) | $5M | $7M | |
| PP&E (Gross) | $24M | $24M | |
| Accum. Depreciation | $19M | $17M | |
| Other Non-current Assets | $3M | $8M | |
| Total Assets | $397M | $241M | |
| Accounts Payable | $2M | $2M | |
| Current Liabilities | $23M | $21M | |
| Capital Leases | $19M | $22M | |
| Other Non-current Liabilities | $1M | $969.0K | |
| Total Liabilities | $42M | $44M | |
| Common Stock | $49.0K | $2.0K | |
| Paid-in Capital | $844M | $47M | |
| Retained Earnings | $-490M | $-358M | |
| Stockholders' Equity | $355M | $-311M | |
| Liabilities + Equity | $397M | $241M | |
| Shares Outstanding | 49,335,551 | 2,446,864 |
Cashflow 7
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Stock-based Comp | $16M | $10M | |
| Operating Cash Flow | $-112M | $76M | |
| CapEx | $794.0K | $1M | |
| Investing Cash Flow | $-171M | $-1M | |
| Financing Cash Flow | $275M | $93M | |
| Taxes Paid | · | $1M | |
| Free Cash Flow | $-113M | · |
Rentabilität 3
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| ROA | -41.1% | · | |
| ROE | -598.9% | · | |
| ROIC | -40.3% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 15.5 | · | |
| Quick Ratio | 15.2 | · |
Bewertung (TTM) 9
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | · | $168M | |
| Net Income TTM | $-131M | $52M | |
| Market Cap | $2.04B | · | |
| P/E | -13.6 | · | |
| P/B | 5.8 | · | |
| P / Tangible Book | 5.8 | · | |
| P / Cash Flow | -18.3 | · | |
| P / FCF | -18.1 | · | |
| Earnings Yield | -7.4% | · |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $20M | · | · | $0 | · | $0 | $165M | |
| R&D Expense | $35M | $34M | $28M | $25M | $28M | $28M | $22M | $20M | |
| SG&A Expense | $13M | $12M | $10M | $8M | $8M | $8M | $8M | $6M | |
| Operating Expenses | $48M | $47M | $38M | $33M | $36M | $35M | $30M | $25M | |
| Operating Income | $-48M | $-27M | $-38M | $-33M | $-36M | $-35M | $-30M | $140M | |
| Other Non-op | $3M | $2M | · | · | $3M | $3M | · | · | |
| Pretax Income | · | · | $-35M | $-30M | $-34M | $-33M | $-30M | $141M | |
| Income Tax | · | · | $0 | $0 | $0 | · | $-275.0K | $2M | |
| Net Income | $-45M | $-24M | $-35M | $-30M | $-34M | $-33M | $-30M | $139M | |
| EPS (Basic) | $-0.76 | $-0.45 | $-0.47 | $-0.66 | $-0.77 | $-1.15 | $19.66 | $5.92 | |
| EPS (Diluted) | $-0.76 | $-0.45 | $-0.47 | $-0.66 | $-0.77 | $-1.15 | $22.19 | $3.22 | |
| Shares (Basic) | 58,995,934 | 53,897,216 | -75,229,404 | 45,779,577 | 43,797,421 | 28,628,430 | -4,745,535 | 2,389,119 | |
| Shares (Diluted) | 58,995,934 | 53,897,216 | -75,229,404 | 45,779,577 | 43,797,421 | 28,628,430 | -6,336,570 | 4,314,359 | |
| EBITDA | $-48M | $-27M | · | $-33M | $-36M | $-35M | · | · |
Bilanz 23
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $203M | $199M | $189M | $317M | $265M | $294M | $197M | · | |
| Short-term Investments | $208M | $154M | $153M | $67M | · | · | · | · | |
| Receivables | · | $20M | · | · | · | · | · | · | |
| Prepaid Expense | $9M | $7M | $8M | $7M | $7M | $5M | $5M | · | |
| Current Assets | $420M | $380M | $350M | $391M | $271M | $300M | $202M | · | |
| PP&E (Net) | $4M | $5M | $5M | $6M | $6M | $6M | $7M | · | |
| PP&E (Gross) | · | · | $24M | · | · | · | $24M | · | |
| Accum. Depreciation | · | · | $19M | · | · | · | $17M | · | |
| Other Non-current Assets | $3M | $4M | $3M | $3M | $4M | $3M | $8M | · | |
| Total Assets | $532M | $420M | $397M | $422M | $304M | $333M | $241M | · | |
| Accounts Payable | $2M | $4M | $2M | $3M | $4M | $2M | $2M | · | |
| Current Liabilities | $23M | $21M | $23M | $22M | $20M | $19M | $21M | · | |
| Capital Leases | $17M | $18M | $19M | $19M | $20M | $21M | $22M | · | |
| Other Non-current Liabilities | · | $388.0K | $1M | $1M | $1M | $1M | $969.0K | · | |
| Total Liabilities | $79M | $78M | $42M | $43M | $41M | $41M | $44M | · | |
| Long-term Debt | $39M | $39M | · | · | · | · | · | · | |
| Total Debt | $39M | $39M | · | · | · | · | · | · | |
| Common Stock | $56.0K | $50.0K | $49.0K | $48.0K | $44.0K | $44.0K | $2.0K | · | |
| Paid-in Capital | $1.01B | $856M | $844M | $834M | $687M | $683M | $47M | · | |
| Retained Earnings | $-558M | $-514M | $-490M | $-455M | $-425M | $-391M | $-358M | · | |
| Stockholders' Equity | $453M | $342M | $355M | $379M | $262M | $292M | $-311M | · | |
| Liabilities + Equity | $532M | $420M | $397M | $422M | $304M | $333M | $241M | · | |
| Shares Outstanding | 55,504,574 | 49,737,619 | 49,335,551 | 48,076,885 | 43,850,884 | 43,797,166 | 2,446,864 | · |
Cashflow 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $9M | $7M | $6M | $4M | $3M | $3M | $3M | $2M | |
| Operating Cash Flow | $-15M | $-39M | $-28M | $-25M | $-30M | $-30M | $-22M | $145M | |
| CapEx | $107.0K | $93.0K | $34.0K | $68.0K | $393.0K | $299.0K | $605.0K | $160.0K | |
| Investing Cash Flow | $-129M | $6M | $-103M | $-67M | $-393.0K | $-299.0K | $-605.0K | $-160.0K | |
| Financing Cash Flow | $147M | $42M | $4M | $144M | $612.0K | $127M | $70M | $154.0K | |
| Taxes Paid | · | · | · | · | · | · | $0 | · | |
| Free Cash Flow | · | $-39M | · | · | · | $-30M | · | · |
Rentabilität 6
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -132.8% | · | · | · | · | · | · | |
| Net Margin | · | -121.0% | · | · | · | · | · | · | |
| EBITDA Margin | · | -132.8% | · | · | · | · | · | · | |
| ROA | -10.7% | -6.4% | · | -14.3% | -22.2% | -19.7% | · | · | |
| ROE | -12.5% | -7.6% | · | -15.9% | -25.7% | -22.4% | · | · | |
| ROIC | · | · | · | -8.7% | -13.9% | · | · | · |
Liquidität & Solvenz 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 18.3 | 17.9 | · | 17.7 | 13.6 | 16.1 | · | · | |
| Quick Ratio | 17.9 | 17.5 | · | 17.4 | 13.3 | 15.8 | · | · | |
| Debt / Equity | 0.1 | 0.1 | · | · | · | · | · | · | |
| LT Debt / Equity | 0.1 | 0.1 | · | · | · | · | · | · |
Effizienz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.1 | · | · | 0.0 | · | · | · | |
| Receivables Turnover | · | 2.0 | · | · | · | · | · | · |
Bewertung (TTM) 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-133M | $-121M | · | $-121M | $48M | $49M | · | · | |
| Market Cap | $1.66B | $1.48B | · | $1.25B | $538M | $482M | · | · | |
| Enterprise Value | $1.28B | $1.17B | · | · | · | · | · | · | |
| P/E | -11.3 | -9.9 | · | -2.0 | -1.4 | -0.5 | · | · | |
| P/B | 3.7 | 4.3 | · | 3.3 | 2.1 | 1.7 | · | · | |
| P / Tangible Book | 3.7 | 4.3 | · | 3.3 | 2.1 | 1.7 | · | · | |
| P / Cash Flow | · | -38.0 | · | · | · | -16.3 | · | · | |
| P / FCF | · | -37.9 | · | · | · | -16.2 | · | · | |
| EV / EBITDA | -26.7 | -44.1 | · | · | · | · | · | · | |
| EV / FCF | · | -29.9 | · | · | · | · | · | · | |
| Earnings Yield | -8.8% | -10.2% | · | -49.5% | -72.9% | -200.6% | · | · |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Umsatz | — | $168M |
| Nettoergebnis | $-131M | $52M |
| Verwässerte EPS | $-3.05 | $1.25 |
Bilanz
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Liquiditätsgrad | 15.5 | — |
| Quick Ratio | 15.2 | — |
Cashflow
| 2025-12-31 | 2024-12-31 | |
|---|---|---|
| Freier Cashflow | $-113M | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 174 Einreicher · $1.5B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 46 (-9 vs. Vorquartal) | 41 (+16 vs. Vorquartal) | 60 (+8 vs. Vorquartal) | 39 (+1 vs. Vorquartal) | +4.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | $150.182.184 | 5.032.915 | 10,06% | Aktien |
| TRV GP IV, LLC | $133.502.907 | 4.473.958 | 8,94% | Aktien |
| ARCH Venture Management, LLC | $122.983.582 | 4.120.053 | 8,24% | Aktien |
| Deep Track Capital, LP | $111.379.859 | 3.732.569 | 7,46% | Aktien |
| JANUS HENDERSON GROUP PLC | $85.280.271 | 2.858.876 | 5,71% | Aktien |
| Logos Global Management LP | $57.740.400 | 1.935.000 | 3,87% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $53.062.144 | 1.778.222 | 3,55% | Aktien |
| a16z Capital Management, L.L.C. | $50.794.394 | 1.702.225 | 3,40% | Aktien |
| Venrock Adviser, LLC | $47.804.695 | 1.602.034 | 3,20% | Aktien |
| Alphabet Inc. | $41.435.317 | 1.388.583 | 2,78% | Aktien |
| BRAIDWELL LP | $34.018.794 | 1.140.040 | 2,28% | Aktien |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $33.057.170 | 1.107.814 | 2,21% | Aktien |
| General Catalyst Group Management, LLC | $30.911.554 | 1.035.910 | 2,07% | Aktien |
| STATE STREET CORP | $29.766.385 | 997.533 | 1,99% | Aktien |
| Driehaus Capital Management LLC | $28.493.798 | 954.886 | 1,91% | Aktien |
| TRV GP V, LLC | $28.371.872 | 950.800 | 1,90% | Aktien |
| FMR LLC | $27.297.662 | 914.801 | 1,83% | Aktien |
| MARSHALL WACE, LLP | $27.290.827 | 914.572 | 1,83% | Aktien |
| Casdin Capital, LLC | $25.180.693 | 843.857 | 1,69% | Aktien |
| ArrowMark Colorado Holdings LLC | $22.898.709 | 767.383 | 1,53% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $22.104.385 | 740.626 | 1,48% | Aktien |
| Woodline Partners LP | $21.968.685 | 736.216 | 1,47% | Aktien |
| JPMORGAN CHASE & CO | $20.547.602 | 707.191 | 1,38% | Aktien |
| CITADEL ADVISORS LLC | $18.763.392 | 628.800 | 1,26% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $12.460.110 | 417.564 | 0,83% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $11.730.313 | 393.107 | 0,79% | Aktien |
| Aberdeen Group plc | $11.451.786 | 383.773 | 0,77% | Aktien |
| Ikarian Capital, LLC | $11.309.331 | 378.999 | 0,76% | Aktien |
| HHLR ADVISORS, LTD. | $10.922.276 | 366.028 | 0,73% | Aktien |
| ADAR1 Capital Management, LLC | $10.123.996 | 339.276 | 0,68% | Aktien |
| Squadron Capital Management LLC | $9.996.400 | 335.000 | 0,67% | Aktien |
| BANK OF AMERICA CORP /DE/ | $9.307.902 | 311.927 | 0,62% | Aktien |
| Candriam S.C.A. | $8.166.266 | 273.932 | 0,55% | Aktien |
| Hudson Bay Capital Management LP | $8.056.800 | 270.000 | 0,54% | Aktien |
| GOLDMAN SACHS GROUP INC | $7.896.410 | 264.625 | 0,53% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $7.775.289 | 260.566 | 0,52% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $7.400.320 | 248.000 | 0,50% | Aktien |
| Mass General Brigham, Inc | $7.161.421 | 239.994 | 0,48% | Aktien |
| AMERIPRISE FINANCIAL INC | $6.786.363 | 227.425 | 0,45% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $6.562.950 | 219.938 | 0,44% | Aktien |
| RTW INVESTMENTS, LP | $6.326.080 | 212.000 | 0,42% | Aktien |
| VANGUARD GROUP INC | $6.060.795 | 146.290 | 0,41% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $5.796.288 | 199.872 | 0,39% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $5.757.688 | 192.952 | 0,39% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $5.635.493 | 188.857 | 0,38% | Aktien |
| ExodusPoint Capital Management, LP | $5.468.598 | 183.264 | 0,37% | Aktien |
| SummitTX Capital, L.P. | $5.260.523 | 176.291 | 0,35% | Aktien |
| HighVista Strategies LLC | $4.075.308 | 136.572 | 0,27% | Aktien |
| Qube Research & Technologies Ltd | $3.910.323 | 131.043 | 0,26% | Aktien |
| Walleye Capital LLC | $3.819.699 | 128.006 | 0,26% | Aktien |
| Exome Asset Management LLC | $3.422.409 | 114.692 | 0,23% | Aktien |
| Ensign Peak Advisors, Inc | $3.033.057 | 101.644 | 0,20% | Aktien |
| Alyeska Investment Group, L.P. | $2.984.000 | 100.000 | 0,20% | Aktien |
| ALGERT GLOBAL LLC | $2.785.773 | 93.357 | 0,19% | Aktien |
| BlackRock, Inc. | $2.602.794 | 87.225 | 0,17% | Aktien |
| UBS Group AG | $2.523.181 | 84.557 | 0,17% | Aktien |
| Trexquant Investment LP | $2.436.973 | 81.668 | 0,16% | Aktien |
| FRANKLIN RESOURCES INC | $2.321.104 | 77.785 | 0,16% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $2.305.170 | 77.251 | 0,15% | Aktien |
| XTX Topco Ltd | $2.247.459 | 75.317 | 0,15% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $2.219.617 | 74.384 | 0,15% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1.953.565 | 65.468 | 0,13% | Aktien |
| DAFNA Capital Management LLC | $1.939.600 | 65.000 | 0,13% | Aktien |
| ALPS ADVISORS INC | $1.670.145 | 55.970 | 0,11% | Aktien |
| Jump Financial, LLC | $1.406.329 | 47.129 | 0,09% | Aktien |
| Swiss National Bank | $1.405.464 | 47.100 | 0,09% | Aktien |
| FIRST TRUST ADVISORS LP | $1.379.413 | 46.227 | 0,09% | Aktien |
| Propel Bio Management, LLC | $1.306.932 | 43.798 | 0,09% | Aktien |
| RHUMBLINE ADVISERS | $1.279.322 | 42.873 | 0,09% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $1.128.330 | 37.800 | 0,08% | Aktien |
| Bank of New York Mellon Corp | $979.975 | 32.841 | 0,07% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $969.800 | 32.500 | 0,06% | Verkaufsoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $954.880 | 32.000 | 0,06% | Kaufoption |
| WELLS FARGO & COMPANY/MN | $947.330 | 31.747 | 0,06% | Aktien |
| Quadrature Capital Ltd | $896.602 | 30.047 | 0,06% | Aktien |
| CITIGROUP INC | $842.353 | 28.229 | 0,06% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $792.819 | 26.569 | 0,05% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $782.256 | 26.215 | 0,05% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $711.386 | 23.840 | 0,05% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $706.522 | 23.677 | 0,05% | Aktien |
| TD Asset Management Inc | $661.672 | 22.174 | 0,04% | Aktien |
| NOMURA HOLDINGS INC | $626.640 | 21.000 | 0,04% | Kaufoption |
| NOMURA HOLDINGS INC | $626.640 | 21.000 | 0,04% | Verkaufsoption |
| MetLife Investment Management, LLC | $623.626 | 20.899 | 0,04% | Aktien |
| BARCLAYS PLC | $614.882 | 20.606 | 0,04% | Aktien |
| TWO SIGMA ADVISERS, LP | $613.164 | 14.800 | 0,04% | Aktien |
| Balyasny Asset Management L.P. | $602.470 | 20.190 | 0,04% | Aktien |
| Squarepoint Ops LLC | $579.911 | 19.434 | 0,04% | Aktien |
| Verition Fund Management LLC | $543.118 | 18.201 | 0,04% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $490.450 | 16.436 | 0,03% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $489.436 | 16.402 | 0,03% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $484.840 | 16.248 | 0,03% | Aktien |
| MORGAN STANLEY | $463.893 | 15.546 | 0,03% | Aktien |
| AXQ CAPITAL, LP | $453.359 | 15.193 | 0,03% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $428.801 | 14.370 | 0,03% | Aktien |
| Invesco Ltd. | $419.550 | 14.060 | 0,03% | Aktien |
| China Universal Asset Management Co., Ltd. | $412.031 | 13.808 | 0,03% | Aktien |
| Virtus Investment Advisers, LLC | $405.973 | 13.605 | 0,03% | Aktien |
| Verdad Advisers, LP | $376.521 | 12.618 | 0,03% | Aktien |
| CITADEL ADVISORS LLC | $375.984 | 12.600 | 0,03% | Kaufoption |
Unternehmensinsider 11 Insider · 1 Führungskräfte · 6 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Atul Dandekar | CSBO | 29. Juli 2026 M | 26.250 | 0 | 4 | $-612.761 |
| Nancy C Andrews | Direktor | 8. Juni 2026 A | — | 0 | 0 | $0 |
| Herve Hoppenot | Direktor | 8. Juni 2026 A | — | 0 | 0 | $0 |
| Jonathan E Lim | Direktor | 8. Juni 2026 A | — | 0 | 0 | $0 |
| Daniel K Spiegelman | Direktor | 8. Juni 2026 A | — | 0 | 0 | $0 |
| Richard H Scheller | Direktor | 8. Juni 2026 A | 0 | 0 | 1 | $-464.043 |
| Charles J Homcy | Direktor | 8. Juni 2026 A | 31.113 | 0 | 0 | $0 |
| Harold Bernstein | — | 13. August 2026 M | 0 | 0 | 4 | $-1.221.422 |
| Sophie Kornowski | — | 13. August 2026 A | — | 0 | 0 | $0 |
| Paula A Johnson | — | 13. August 2026 A | — | 0 | 0 | $0 |
| Jason V Coloma | — | 3. August 2026 S | 255.263 | 0 | 11 | $-2.841.393 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 39 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0,81% | 49.602 NS | 31. Mai 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 0,71% | 3.421 NS | 30. April 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,51% | 7.102 NS | 30. April 2026 | N-PORT |
| IWC · iShares Trust | 0,23% | 120.190 SH | 8. August 2026 | Täglich |
| IHE · iShares Trust | 0,18% | 100.508 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,12% | 79.727 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,11% | 3.014 SH | 8. August 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,10% | 38.381 NS | 30. April 2026 | N-PORT |
| ESSC · Strategy Shares | 0,10% | 925 NS | 30. April 2026 | N-PORT |
| IBB · iShares Trust | 0,08% | 254.301 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,06% | 1.778 NS | 31. Mai 2026 | N-PORT |
| IWO · iShares Trust | 0,05% | 269.368 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,05% | 31.513 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,03% | 901.580 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,03% | 203.079 SH | 8. August 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,03% | 7.548 NS | 30. April 2026 | N-PORT |
| RSSL · Global X Funds | 0,02% | 11.444 NS | 30. April 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,02% | 3.578 NS | 30. April 2026 | N-PORT |
| ITWO · ProShares Trust | 0,02% | 1.244 NS | 31. Mai 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,01% | 5.055 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,01% | 1.283 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 100.724 NS | 31. Mai 2026 | N-PORT |
| IWN · iShares Trust | 0,01% | 53.236 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,01% | 974 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 325.413 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 5.162 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 70.669 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,01% | 982 NS | 31. Mai 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,01% | 6.267 SH | 8. August 2026 | Täglich |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,01% | 1.092 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 1.441 SH | 8. August 2026 | Täglich |
| ONEQ · Fidelity Commonwealth Trust | 0,00% | 14.208 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 887 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 25 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 46.279 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 5.789 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 11.544 NS | 31. Mai 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.411.990 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.957 SH | 8. August 2026 | Täglich |